PhaseV’s $50 Million Series A Financing Round

Sidley Austin advised PhaseV Trials Inc. on the transaction. PhaseV Trials Inc., a leader in AI/ML-driven clinical development, announced its US$50 million Series A financing round….

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here